2019年度中国医药行业最具影响力榜单更新 瑞康医药再获肯定
2020年8月7日，由全国工商联医药业商会主办的“2019年度中国医药行业最具影响力榜单发布会暨第十三届中国医药产业发展高峰论坛”在南昌召开，瑞康医药集团股份有限公司再次入选“2019年度中国医药行业成长50强”、“2019年度中国医药商业百强”，其行业影响力及品牌知名度逐年夯实！
本次榜单公布了2019年度中国医药工业百强、医药商业百强、连锁药店百强、守法诚信企业等10个奖项，这也是全国工商联医药业商会自2013年以来连续第七届评选，在医药行业内向会员及医药企业广泛征集1100余份参评企业的资料，就上一年度的行业发展信息进行总结梳理，本着公开、公正、公平的原则，经过信息收集、商会初选、评委会终审等程序，最终完成榜单评选工作。
在此次全国工商联医药业商会的评选奖项中，瑞康医药还荣获“2020年抗疫慈善爱心企业”荣誉称号。
2020年新冠疫情发生以来，瑞康医药采购团队、销售团队和物流团队紧急响应集团号召，上下同心，攻坚克难，全力保障服务医疗机构所需医疗产品配送供应。青山一道同云雨，瑞康医药先后通过军委联勤保障部队、红十字会等机构捐赠设备试剂等总额超过4600万元，积极驰援医疗机构，瑞康医药集团及多家子公司入选全国疫情防控重点保障企业名单，以实际行动展现了“正道瑞祥天际 厚德康达八方”的企业文化。
2019年，瑞康医药以营业收入352.58亿元，位列《财富》中国第275位，稳居医药商业百强榜单第9名，同时再度荣获“医药业成长50强”，彰显出市场及业内对瑞康医药发展前景充满肯定与信心。
2019年，瑞康医药精心谋划顶层设计，科学搭建架构体系；进一步优化业务流程，细化业务布局，搭建起吉祥天、吉祥地、吉祥水、吉祥火、吉祥风、吉祥雷、吉祥山、吉祥泽八大业务板块；加快推进转型升级，聚焦培育创新业务，全力打造行业生态新模式——吉祥天区块链医药健康服务平台已正式上线并开展对外服务，为集团打造中国最具活力的医疗健康生态资源整合者揭开了新的篇章。目前集团已在全国31个省份（直辖市）设立100多家子公司，直接服务于全国4万多家各级医疗机构，是全国药品、医疗器械流通行业的领军企业之一。
{"weixin":{"label":"微信","name":"weixin","selected":true,"value":true,"sortid":"1","shareid":"weixin","sharetitle":"分享到微信","event":"shareToWeiXin","lang":"shareWeb_WeiXin"},"copy":{"label":"复制网址","name":"copy","selected":true,"value":true,"sortid":"2","shareid":"copy","sharetitle":"复制网址","event":"copy_url","lang":"shareWeb_Copy"},"qq":{"label":"QQ好友","name":"qq","selected":true,"value":false,"sortid":"1","shareid":"qq","sharetitle":"分享到QQ","event":"shareToQQ","lang":"shareWeb_QQ"},"sina_weibo":{"label":"新浪微博","name":"sina_weibo","selected":true,"value":true,"sortid":"4","shareid":"sina_weibo","sharetitle":"分享到新浪微博","event":"shareToSinaWB","lang":"shareWeb_SinaWeiBo"},"qq_zone":{"label":"QQ空间","name":"qq_zone","selected":true,"value":true,"sortid":"5","shareid":"qq_zone","sharetitle":"分享到QQ空间","event":"shareToQzone","lang":"shareWeb_QQZone"},"renren":{"label":"人人网","name":"renren","selected":true,"value":true,"sortid":"7","shareid":"renren","sharetitle":"分享到人人网","event":"shareToRenren","lang":"shareWeb_RenRen"},"douban":{"label":"豆瓣网","name":"douban","selected":true,"value":true,"sortid":"8","shareid":"douban","sharetitle":"分享到豆瓣网","event":"shareToDouban","lang":"shareWeb_DouBan"},"baidu_tieba":{"label":"百度贴吧","name":"baidu_tieba","selected":true,"value":true,"sortid":"10","shareid":"baidu_tieba","sharetitle":"分享到百度贴吧","event":"shareToTieba","lang":"shareWeb_TieBa"},"Facebook":{"label":"Facebook","name":"Facebook","selected":true,"value":true,"sortid":"11","shareid":"Facebook","sharetitle":"分享到FaceBook","event":"shareToFacebook","lang":"shareWeb_Facebook"},"Twitter":{"label":"Twitter","name":"Twitter","selected":true,"value":true,"sortid":"12","shareid":"Twitter","sharetitle":"分享到Twitter","event":"shareToTwitter","lang":"shareWeb_Twitter"},"LinkedIn":{"label":"LinkedIn","name":"LinkedIn","selected":true,"value":true,"sortid":"13","shareid":"LinkedIn","sharetitle":"分享到linkedIn","event":"shareToLinkedin","lang":"shareWeb_Linkedin"},"whatsapp":{"label":"whatsapp","name":"whatsapp","selected":true,"value":true,"sortid":"15","shareid":"whatsapp","sharetitle":"分享到whatsapp","event":"shareToWhatsapp","lang":"shareWeb_whatsapp"},"line":{"label":"line","name":"line","selected":true,"value":true,"sortid":"15","shareid":"line","sharetitle":"分享到line","event":"shareToLine","lang":"shareWeb_line"},"qq_weibo":{"label":"腾讯微博","name":"qq_weibo","selected":true,"value":true,"sortid":"3","shareid":"qq_weibo","sharetitle":"分享到腾讯微博","event":"shareToQQwb","lang":"shareWeb_QQWeiBo"},"peopleBlog":{"label":"人民微博","name":"propleBlog","selected":true,"value":true,"sortid":"14","shareid":"propleBlog","sharetitle":"分享到人民微博","event":"shareToPeopleBlog","lang":"shareWeb_peopleBlog"}}
